Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Center for Biotechnology (NCB) is a prominent research and development organization based in Saudi Arabia, operating under the King Abdulaziz City for Science and Technology (KACST). The center focuses on advancing biotechnology through genomics, proteomics, and bioinformatics to address national challenges in healthcare, agriculture, and the environment. NCB's primary business involves conducting high-impact research, developing diagnostic tools, and exploring therapeutic interventions for genetic and infectious diseases. By fostering collaborations with international research institutions and local industries, the center aims to build a robust biotechnology ecosystem and drive innovation in the life sciences sector within the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Center.